Hey, don’t believe me, believe the NY Times
The New York Times Makes A Stunning Admission About CDC Data On Vaccines
The New York Times made an eye-popping admission on Sunday regarding data collected by the Centers for Disease Control (CDC) on Covid-19 vaccines.
In an article titled, “The C.D.C. Isn’t Publishing Large Portions of the Covid Data It Collects,” reporter Apoorva Mandavilli writes: “For more than a year, the Centers for Disease Control and Prevention has collected data on hospitalizations for Covid-19 in the United States and broken it down by age, race and vaccination status. But it has not made most of the information public.”
Mandavilli, who covers science and global health for the Times, reported that the agency has published “only a tiny fraction of the data it has collected” since the pandemic began, including data on booster efficacy for 18 – 49 year-olds, a tremendous chunk of the U.S. population.
You just know that, if the data supported the CDC’s fearmongering and citizen control agenda they’d be publishing it out the wazoo. Here’s one of the best parts
"The C.D.C. has been routinely collecting information since the Covid vaccines were first rolled out last year … The agency has been reluctant to make those figures public … because they might be misinterpreted as the vaccines being ineffective."https://t.co/hecPyHmWQn
— Scott Morefield (@SKMorefield) February 20, 2022
Well, if the data might be misinterpreted, why would that be? And, let’s be honest, they are really mostly only effective in keeping people from getting really sick from Wuhan flu, when they were originally said to keep people from getting it at all. And the article goes on to note that so many have to get their data from nations like Israel, because they aren’t getting it from the CDC. And, you know what they’ve found out?
Got a COVID Booster? You Probably Won’t Need Another for a Long Time
As people across the world grapple with the prospect of living with the coronavirus for the foreseeable future, one question looms large: How soon before they need yet another shot?
Not for many months, and perhaps not for years, according to a flurry of new studies.
Three doses of a COVID vaccine — or even just two — are enough to protect most people from serious illness and death for a long time, the studies suggest. (snip)
The omicron variant can dodge antibodies — immune molecules that prevent the virus from infecting cells — produced after two doses of a COVID vaccine. But a third shot of the mRNA vaccines made by Pfizer-BioNTech or by Moderna prompts the body to make a much wider variety of antibodies, which would be difficult for any variant of the virus to evade, according to the most recent study.
The diverse repertoire of antibodies produced should be able to protect people from new variants, even those that differ significantly from the original version of the virus, the study suggests.
Well, that sounds like a good deal.
A big question now is “will members of the House and Senate ask pointed questions to CDC director Rochelle Walensky over the CDC hiding data from the public?”